195 related articles for article (PubMed ID: 36735782)
1. Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function.
Román-Fernández A; Mansour MA; Kugeratski FG; Anand J; Sandilands E; Galbraith L; Rakovic K; Freckmann EC; Cumming EM; Park J; Nikolatou K; Lilla S; Shaw R; Strachan D; Mason S; Patel R; McGarry L; Katoch A; Campbell KJ; Nixon C; Miller CJ; Leung HY; Le Quesne J; Norman JC; Zanivan S; Blyth K; Bryant DM
Sci Adv; 2023 Feb; 9(5):eabq1858. PubMed ID: 36735782
[TBL] [Abstract][Full Text] [Related]
2. PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer.
Zhang J; Zhu Z; Wu H; Yu Z; Rong Z; Luo Z; Xu Y; Huang K; Qiu Z; Huang C
Gastric Cancer; 2019 Jan; 22(1):48-59. PubMed ID: 29748877
[TBL] [Abstract][Full Text] [Related]
3. Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein.
Zhi Q; Chen H; Liu F; Han Y; Wan D; Xu Z; Kuang Y; Zhou J
Cancer Sci; 2019 Jan; 110(1):118-134. PubMed ID: 30407695
[TBL] [Abstract][Full Text] [Related]
4. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts.
Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203331
[TBL] [Abstract][Full Text] [Related]
5. Podocalyxin is a marker of poor prognosis in colorectal cancer.
Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C
BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863
[TBL] [Abstract][Full Text] [Related]
6. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.
Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Hanazaki K; Saibara T
Cancer Sci; 2016 Oct; 107(10):1430-1442. PubMed ID: 27461278
[TBL] [Abstract][Full Text] [Related]
7. Sperm‑associated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin.
Jiang J; Liu Y; Fang W; Liu F
Mol Med Rep; 2014 Jul; 10(1):417-22. PubMed ID: 24788963
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte-endothelial cell interaction is enhanced in podocalyxin-deficient mice.
Porras G; Ayuso MS; González-Manchón C
Int J Biochem Cell Biol; 2018 Jun; 99():72-79. PubMed ID: 29604348
[TBL] [Abstract][Full Text] [Related]
9. Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy.
Snyder KA; Hughes MR; Hedberg B; Brandon J; Hernaez DC; Bergqvist P; Cruz F; Po K; Graves ML; Turvey ME; Nielsen JS; Wilkins JA; McColl SR; Babcook JS; Roskelley CD; McNagny KM
Breast Cancer Res; 2015 Mar; 17(1):46. PubMed ID: 25887862
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL.
Chijiiwa Y; Moriyama T; Ohuchida K; Nabae T; Ohtsuka T; Miyasaka Y; Fujita H; Maeyama R; Manabe T; Abe A; Mizuuchi Y; Oda Y; Mizumoto K; Nakamura M
Int J Oncol; 2016 Apr; 48(4):1688-700. PubMed ID: 26892887
[TBL] [Abstract][Full Text] [Related]
11. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
Larsson AH; Lehn S; Wangefjord S; Karnevi E; Kuteeva E; Sundström M; Nodin B; Uhlén M; Eberhard J; Birgisson H; Jirström K
J Transl Med; 2016 May; 14(1):128. PubMed ID: 27160084
[TBL] [Abstract][Full Text] [Related]
12. Distinct Functional Requirements for Podocalyxin in Immature and Mature Podocytes Reveal Mechanisms of Human Kidney Disease.
Refaeli I; Hughes MR; Wong AK; Bissonnette MLZ; Roskelley CD; Wayne Vogl A; Barbour SJ; Freedman BS; McNagny KM
Sci Rep; 2020 Jun; 10(1):9419. PubMed ID: 32523052
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.
Kusumoto H; Shintani Y; Kanzaki R; Kawamura T; Funaki S; Minami M; Nagatomo I; Morii E; Okumura M
Cancer Sci; 2017 Mar; 108(3):528-535. PubMed ID: 28004467
[TBL] [Abstract][Full Text] [Related]
14. Novel roles for podocalyxin in regulating stress myelopoiesis, Rap1a, and neutrophil migration.
Li P; Karaczyn AA; McGlauflin R; Favreau-Lessard AJ; Jachimowicz E; Vary CP; Xu K; Wojchowski DM; Sathyanarayana P
Exp Hematol; 2017 Jun; 50():77-83.e6. PubMed ID: 28408238
[TBL] [Abstract][Full Text] [Related]
15. High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2.
San IV; Prost G; Williams JA; Moss SE; Nuber UA
Biochem Biophys Res Commun; 2016 Sep; 478(2):573-9. PubMed ID: 27470587
[TBL] [Abstract][Full Text] [Related]
16. PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.
Ogasawara S; Kaneko MK; Yamada S; Honma R; Nakamura T; Saidoh N; Yanaka M; Yoshida K; Fujii Y; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Apr; 36(2):50-56. PubMed ID: 28384052
[TBL] [Abstract][Full Text] [Related]
17. Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation.
Cait J; Hughes MR; Zeglinski MR; Chan AW; Osterhof S; Scott RW; Canals Hernaez D; Cait A; Vogl AW; Bernatchez P; Underhill TM; Granville DJ; Murphy TH; Roskelley CD; McNagny KM
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4518-4527. PubMed ID: 30787191
[TBL] [Abstract][Full Text] [Related]
18. Podocalyxin Expressed in Antigen Presenting Cells Promotes Interaction With T Cells and Alters Centrosome Translocation to the Contact Site.
Amo L; Díez-García J; Tamayo-Orbegozo E; Maruri N; Larrucea S
Front Immunol; 2022; 13():835527. PubMed ID: 35711462
[TBL] [Abstract][Full Text] [Related]
19. Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells.
Larrucea S; Butta N; Arias-Salgado EG; Alonso-Martin S; Ayuso MS; Parrilla R
Exp Cell Res; 2008 Jun; 314(10):2004-15. PubMed ID: 18456258
[TBL] [Abstract][Full Text] [Related]
20. Podocalyxin-like, targeted by miR-138, promotes colorectal cancer cell proliferation, migration, invasion and EMT.
Xu Y; Pan ZG; Shu L; Li QJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8664-8674. PubMed ID: 30575907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
